Skip to content

REPROS THERAPEUTICS INC.

CIK 0000897075

← back to feed
Revenue (TTM)
$328K
−50.0% YoY Q3 Nov 2017
Net Income (TTM)
−$13.89M
+4.5% YoY Q3 Nov 2017
EPS Diluted (TTM)
−$0.70
+41.7% YoY Q3 Nov 2017
Gross Margin
—
Q3 Nov 2017
Operating Margin
—
Q3 Nov 2017
Net Margin
-4,235.7%
Q3 Nov 2017
Free Cash Flow (TTM)
−$26.71M
Q3 Nov 2017
Cash
$1.81M
Q3 Nov 2017
Total Debt
—
Q3 Nov 2017
Shares Outstanding
39.56M sh
Q3 Nov 2017

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings